More than 99 percent of cervical cancers are caused by persistent high-risk HPV infection 1 Cervical cancer is nearly 100 percent preventable with proper HPV vaccination, screening and treatment; ...

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with nearly one-third being unsure or unaware of it altogether.1 Findings ...

The FDA has approved an alternative to the traditional Pap smear. The U.S. Food and Drug Administration has approved a genetic test from Swiss drug maker Roche as the first U.S.-approved alternative ...

Let's be honest: Pap smears are terrible. Every year, I stare at the ceiling and try my hardest to ignore the scraping of my insides. In the age of AI chatbots and self-driving cars, how has no one ...

However, more than 70% of the respondents indicated they would be interested in the option of collecting their own sample for screening if available. The research also demonstrated that with screening ...

Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results Dual-stain biomarkers aid in ...

The Food and Drug Administration approved the Roche cobas HPV Test to detect human papilloma virus through the use of cervical cells collected for a Pap test and stored in SurePath Preservative Fluid.

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV. With the test, ...

LOS ANGELES, March 13 (Reuters) - U.S. health experts recommended that a test for cancer-causing strains of the human papillomavirus (HPV) be approved to replace Pap smears in screening most women for ...

The U.S. Food and Drug Administration’s Medical Devices Advisory Committee Microbiology Panel unanimously voted that Roche Molecular Systems’ cobas viral DNA test is safe and effective as a ...